Forward-looking predictions and analyst price targets for Cresco Labs are closely tied to potential federal cannabis reform, such as potential rescheduling under federal guidelines and broader capital market access. While long-term forecasts outline potential upside if federal prohibition eases, near-term projections remain cautious due to ongoing state-level pricing pressures and regulatory complexities.